Alnylam Pharmaceuticals
ALNY
#593
Rank
$42.93 B
Marketcap
$321.59
Share price
2.73%
Change (1 day)
-0.78%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company